AIDAC gave a positive opinion
On January 22, 2015 the Anti-Infective Drug Advisory Committee (AIDAC) gave a positive opinion of isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis. The hearing at FDA Headquarters in Washington DC can be accessed online through the following links.
January 22, 2015, Meeting of the Anti-Infective Drugs Advisory
Committee (AIDAC) – Webcast Recording
The Center for Drug Evaluation and Research (CDER) provided a live webcast of the January 22, 2015, meeting of the Anti-Infective Drugs Advisory Committee.
A recording of the webcast can be found at the following address:
• Start of Meeting to Morning Break: https://collaboration.fda.gov/p9rzp8kdysh/
• Morning Break to Lunch Break: https://collaboration.fda.gov/p5kzjjfh4t3/
• Lunch Break to End of Meeting: https://collaboration.fda.gov/p4gxk2749st/
The webcast was broadcast using Adobe Connect. You can make sure your computer has the correct
plug-ins to view the webcast at this web site: